Clinical trials: High-altitude Polycythemia
High-altitude Polycythemia, HAPC
High-Altitude Polycythemia Study
This study aims to evaluate the clinical efficacy of non-invasive ventilation (NIV) in treating patients with high-altitude polycythemia (HAPC).
- Trial name
- NIV-HAPC (NCT07600086)
- Testing
- Non-invasive ventilator
- Where
- 2 sites in China
- Volunteers
- 70 people
- Sponsor
- Tibet Autonomous Region People's Hospital
High Altitude Polycythemia
Remote Ischemic Conditioning for High Altitude Polycythemia in High-Altitude Immigrant Populations
This study is a multicenter, prospective, randomized, open-label, parallel-controlled clinical trial. The participants are adult patients with high-altitude polycythemia who have been long-term residents (for >6 months) in…
- Trial name
- NCT07562464
- Testing
- RIC
- Volunteers
- 222 people
- Sponsor
- Capital Medical University
High Altitude Polycythemia
The Efficacy of Combination of Traditional Tibetan and Remote Ischemic Conditioning on High Altitude Polycythemia
A multicenter, randomized controlled trial was designed to evaluate the effectiveness and safety of the comprehensive traditional Tibetan medicine program combined with remote ischemic conditioning on high altitude polycythemia.
- Trial name
- NCT06082583
- Testing
- Remote Ischemic Conditioning, Tibetan Medicine (Shiliu Jianwei Powder, Ershiwuwei Yuganzi Pills, Qiwei Tiexue Pill)
- Volunteers
- 300 people
- Sponsor
- Capital Medical University
High Altitude Polycythemia
Treatment of High Altitude Polycythemia by Acetazolamide
The prevalence of High Altitude Polycythemia (or Chronic Mountain Sickness) is between 8 and 15% in the high altitude regions of South America. There is no pharmacological treatment available.
- Trial name
- NCT00424970
- Testing
- acetazolamide
- Where
- Peru
- Volunteers
- 55 people
- Sponsor
- Association pour la Recherche en Physiologie de l'Environnement